Iterum regains Nasdaq compliance with minimum bid price rule

Iterum Therapeutics plc

Received letter from Nasdaq on Dec 4, 2023 confirming compliance with Bid Price Rule.
Previously notified of deficiency on Sept 26, 2023; compliance deadline was March 25, 2024.
Achieved minimum $1.00 closing bid price for 10 consecutive trading days through Nov 30, 2023.

item 8.01 item 9.01

Iterum Therapeutics plc filing history →

Source: SEC EDGAR

accession 0000950170-23-067481

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.